Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Search by expertise, name or affiliation
Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor?
D. H. Johnson
Int Med - Chairman's Office
Contribution to journal
Dive into the research topics of 'Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor?'. Together they form a unique fingerprint.